78132 Federal Register / Vol. 85, No. 233 / Thursday, December 3, 2020 / Notices 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2020–26630 Filed 12–2–20; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–21–1074] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled Colorectal 

Cancer Control (CRCCP) Monitoring 

Activities to the Office of Management 

and Budget (OMB) for review and 

approval. CDC previously published a 

‘‘Proposed Data Collection Submitted 

for Public Comment and 

Recommendations’’ notice on June 5, 

2020 to obtain comments from the 

public and affected agencies. CDC 

received two non-substantive public 

comments and provided responses to 

each. This notice serves to allow an 

additional 30 days for public and 

affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Colorectal Cancer Control Program 

(CRCCP) Monitoring Activities (OMB 

Control No. 0920–1074, Exp. 7/31/ 

2020)—Reinstatement with Change— 

National Center for Chronic Disease 

Prevention and Health Promotion 

(NCCDPHP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

CDC is requesting a Reinstatement 

with Change to OMB Control No. 0920– 

1074. CDC proposes use of a modified 

annual grantee survey instrument 

(renamed ‘‘Annual Awardee Survey’’), a 

modified clinic-level data collection 

instrument, and a new awardee-level 

Quarterly Program Update. The number 

of respondents will increase from 30 to 

35 awardees, and the total estimated 

annualized burden will increase. 

Colorectal cancer (CRC) is the second 

leading cause of death from cancer in 

the United States among cancers that 

affect both men and women. There is 

substantial evidence that CRC screening 

reduces the incidence of and death from 

the disease. Screening for CRC can 

detect disease early, when treatment is 

more effective, and prevent cancer by 

finding and removing precancerous 

polyps. Of individuals diagnosed with 

early stage CRC, more than 90% live 

five or more years. To reduce CRC 

morbidity, mortality, and associated 

costs, use of CRC screening tests must 

be increased among age-eligible adults 

with the lowest CRC screening rates. 

The purpose of the Colorectal Cancer 

Control Program (CRCCP) is to partner 

with health systems and their 

individual primary care clinics to 

implement evidence-based 

interventions (EBIs) to increase CRC 

screening among defined populations of 

adults ages 50–75 that have CRC 

screening rates lower than the national, 

regional, or local rate. 

In 2020, CDC issued a new funding 

opportunity, Public Health and Health 

System Partnerships to Increase 

Colorectal Cancer Screening in Clinical 

Settings (DP20–2002), a five-year 

cooperative agreement to increase CRC 

screening among defined populations of 

adults ages 50–75 that have CRC 

screening rates lower than the national, 

regional, or local rate. DP20–2002 funds 

recipients to partner with health 

systems and their primary care clinics to 

implement multiple EBIs, partner with 

organizations to support 

implementation of EBIs in those clinics, 

and collect high-quality clinic-level data 

when a clinic is recruited to participate 

(baseline) and annually thereafter to 

monitor EBI implementation and assess 

screening rate changes. DP20–2002 

eliminates funding to provide direct 

clinical service delivery. However, 

DP20–2002 requires recipients to 

conduct a formal readiness assessment 

of potential clinics to implement EBIs, 

use assessment findings to select 

appropriate EBIs for implementation, 

and provide clinics with limited 

financial resources to support follow-up 

colonoscopies for under- and uninsured 

patients after an abnormal CRC 

screening test. 

CDC proposes three information 

collections—a modified Annual 

Awardee Survey, a modified ClinicLevel Data Collection Instrument, and a 

new awardee-level Quarterly Program 

Update—to reflect modified goals for 

the new cooperative agreement and a 

modified monitoring plan. 

The Annual Awardee Survey 

eliminates questions related to clinic 

service delivery, which is no longer 

funded under DP20–2002. In addition, 

many program management questions 

were eliminated and will now be 

gathered via the Quarterly Program 

Update on a quarterly basis to better 

inform CDC technical assistance (TA). 

The survey now includes five items 

regarding the effect of COVID–19 on 

CRCCP implementation at the grantee 

level. 

The modified clinic-level data 

collection instrument was reorganized 

for increased efficiency and overall data 

quality improvement. In addition, 

wording and responses for many 

variables and their response options 

have undergone minor revisions to 

better capture awardees’ partnerships 

with both health systems and clinics, 

and appropriate capture of baseline and 

annual variables. The instrument 

gathers information to assess health 

system and clinic characteristics; 

program reach; CRC screening practices 

and outcomes; clinics’ quality 

improvement and monitoring activities; 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 85, No. 233 / Thursday, December 3, 2020 / Notices 78133 

EBI implementation; additional factors 

that affect EBI implementation over 

time; and the effect of COVID–19 on 

CRCCP implementation at the clinic 

level. 

The new Quarterly Program Update 

survey will collect standardized 

awardee-level information on aspects of 

program management, including (1) 

respondent information, (2) award 

spending, (3) staff vacancies, (4) 

program successes and challenges, (5) 

TA needs, and (6) COVID–19. This 

information collection will provide CDC 

staff rapid reporting of programmatic 

information to inform their efforts to 

provide awardees with tailored TA. 

Redesigned data elements will enable 

CDC to better gauge progress in meeting 

CRCCP program goals and monitor 

implementation activities, evaluate 

outcomes, and identify awardee TA 

needs. In addition, data collected will 

inform program improvement and help 

identify successful activities that need 

to be maintained, replicated, or 

expanded. 

OMB approval is requested for three 

years. The number of awardees will 

increase from 30 to 35 awardees, and 

the number of clinic partners is 

expected to increase from 12 to 24 per 

awardee. Therefore, the total estimated 

annualized burden hours have increased 

from 204 to 760 hours. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hr) 

CRCCP Awardees ........................ CRCCP Annual Awardee Survey ..................................... 35 1 15/60 

CRCCP Clinic-level Data Collection Instrument .............. 35 24 50/60 

CRCCP Quarterly Program Update ................................. 35 4 22/60 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2020–26631 Filed 12–2–20; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–21–1108; Docket No. CDC–2020– 

0119] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on the 

existing information collection project 

titled Paul Coverdell National Acute 

Stroke Program (PCNASP) reporting 

system, which was established to 

improve quality of care for acute stroke 

patients from onset of signs and 

symptoms through hospital care and 

rehabilitation and recovery. 

DATES: CDC must receive written 

comments on or before February 1, 

2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2020– 

0119 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7118; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

5. Assess information collection costs. 

Proposed Project 

Paul Coverdell National Acute Stroke 

Program (PCNASP) (OMB Control No. 

0920–1108, Exp. 09/30/2022)— 

Revision—National Center for Chronic 

Disease Prevention and Health 

Promotion (NCCDPHP), Centers for 

Disease Control and Prevention (CDC). 


khammond on DSKJM1Z7X2PROD with NOTICES